21 results
424B5
ORIC
ORIC Pharmaceuticals Inc
21 Dec 22
Prospectus supplement for primary offering
5:23pm
and restated bylaws provide that stockholders seeking to nominate candidates for election as directors at an annual or special meeting of stockholders … called annual or special meeting of stockholders and may not be effected by written consent.
Amending our certificate of incorporation and bylaws
Our
POS AM
ORIC
ORIC Pharmaceuticals Inc
22 Mar 22
Prospectus update (post-effective amendment)
4:07pm
as directors at an annual or special meeting of stockholders must provide timely notice thereof in writing. To be timely, a stockholder’s notice generally must … by the stockholders must be effected at a duly called annual or special meeting of stockholders and may not be effected by written consent.
Amending
POSASR
ORIC
ORIC Pharmaceuticals Inc
21 Mar 22
Automatic shelf registration (post-effective amendment)
4:02pm
as directors at an annual or special meeting of stockholders must provide timely notice thereof in writing. To be timely, a stockholder’s notice generally … by the stockholders must be effected at a duly called annual or special meeting of stockholders and may not be effected by written consent.
Amending
424B5
ORIC
ORIC Pharmaceuticals Inc
6 May 21
Prospectus supplement for primary offering
5:01pm
or special meeting of stockholders must provide timely notice thereof in writing. To be timely, a stockholder’s notice generally must be delivered … must be effected at a duly called annual or special meeting of stockholders and may not be effected by written consent.
Amending our certificate
S-3ASR
078j 68jheulx
6 May 21
Automatic shelf registration
4:33pm
424B4
1dgl3qku7g7s j6
13 Nov 20
Prospectus supplement with pricing info
5:21pm
DRS
nyhw8l 8b
20 Jul 20
Draft registration statement
12:00am
8-K
EX-3.2
yc4gy y0nv47oiqa
28 Apr 20
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
5:22pm
8-K
EX-3.1
3adt nd7h
28 Apr 20
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
5:22pm
424B4
5b723 g27
24 Apr 20
Prospectus supplement with pricing info
5:04pm
S-1/A
nyu9sg8o8vj
20 Apr 20
IPO registration (amended)
6:17am
S-1/A
EX-3.4
iqr6 dps3igv
20 Apr 20
IPO registration (amended)
6:17am
S-1
EX-3.4
bmuzu
28 Feb 20
IPO registration
5:32pm
S-1
EX-3.3
qxbzv5w11j8hwz9h kxt
28 Feb 20
IPO registration
5:32pm
S-1
5vq1 a3obnq
28 Feb 20
IPO registration
5:32pm
S-1
EX-3.2
jec5w0ifc0qmwdvq
28 Feb 20
IPO registration
5:32pm
DRS/A
2gjot
24 Jan 20
Draft registration statement (amended)
12:00am
DRS
EX-3.3
9j79ukhlr7dbyi3
13 Dec 19
Draft registration statement
12:00am